[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338512-105":59,"doc-detail-338512-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinical-risk-factors-for-cutaneous-squamous-cell-carcinoma-in-patients-with-actinic-keratosis-or-cutaneous-squamous-cell-carcinoma-in-situ-a-retrospective-double-cohort-study","Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ - A Retrospective Double-cohort Study","","This single-centre retrospective double-cohort study evaluates clinical and patient-related risk factors for developing cutaneous squamous cell carcinoma after an initial precancerous keratinocyte lesion. Patients with histopathologically confirmed actinic keratosis (n=121) or cutaneous squamous cell carcinoma in situ (n=99) were followed for 5 years. Severe dysplasia was linked to faster progression. Advanced age, male sex, basal cell carcinoma comorbidity, and immunosuppressive medication increased risk, with aspirin showing an association limited to cSCCIS-origin cases.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-risk-factors-for-cutaneous-squamous-cell-carcinoma-in-patients-with-actinic-keratosis-or-cutaneous-squamous-cell-carcinoma-in-situ-a-retrospective-double-cohort-study/338512/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-risk-factors-for-cutaneous-squamous-cell-carcinoma-in-patients-with-actinic-keratosis-or-cutaneous-squamous-cell-carcinoma-in-situ-a-retrospective-double-cohort-study/338512.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study design and observation period?","Question",{"text":112,"@type":113},"The study used a single-centre retrospective double-cohort design, comparing patients with actinic keratosis or cutaneous squamous cell carcinoma in situ as their initial lesion over a 5-year observation period.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors increased the risk of developing cutaneous squamous cell carcinoma overall?",{"text":117,"@type":113},"Advanced age, male sex, comorbidity with basal cell carcinoma, and immunosuppressive medication were associated with elevated risk.",{"name":119,"@type":110,"acceptedAnswer":120},"How did severe dysplasia affect cancer development speed?",{"text":121,"@type":113},"Patients whose initial lesion had severely dysplastic actinic keratosis or severely dysplastic cutaneous squamous cell carcinoma in situ developed cutaneous squamous cell carcinoma more rapidly than those with mild or moderate dysplasia.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338512,1790145414,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","1/12  \nORIGINAL REPORT  \nClinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study  \nJaakko S. KNUUTILA1,2, Olli KAIJALA1,2, Salla LEHTO1,2, Tero VAHLBERG3, Liisa NISSINEN1,2, Veli-Matti KÄHÄRI1,2 and Pilvi RIIHILÄ1,2*  \n1Department of Dermatology, University of Turku and Turku University Hospital, Turku, 2FICAN West Cancer Research Laboratory, University of Turku and Turku University Hospital, Turku, and 3Department of Biostatistics, University of Turku, Turku, Finland  \nActinic keratosis and cutaneoussquamous cell carcinoma in situ are precancerous forms of cutaneous squamous cell carcinoma. In this single-centre retrospective study, patients with histopathologically confirmed actinic keratosis (n= 121) or cutaneous squamous cell carcinoma in situ (n=99) as their initial keratinocyte-derived lesion were compared and evaluated with regard to development of cutaneous squamous cell carcinoma during a 5-year observation period. Patients with severely dysplastic actinic keratosis or cutaneous squamous cell carcinoma in situ as their initial lesion developed cutaneoussquamous cell carcinoma more rapidly than patients with actinic keratosis with mild or moderate dysplasia. With either actinic keratosis or cutaneous squamous cell carcinoma in situ as an initial lesion, advanced age, male sex, comorbidity with basal cell carcinoma, and immunosuppressive medication were associated with elevated risk of cutaneous squamous cell carcinoma development. Regarding solely patient with actinic keratosis as their initial lesion male sex, advanced age, immunosuppressive medication, location of the initial lesion, and degree of dysplasia were associated with the risk of cutaneous squamous cell carcinoma. Among patients with cutaneous squamous cell carcinoma in situ as their initial lesion, only aspirin usage was associated with increased risk of cutaneous squamous cell carcinoma. This study indicates that, among the vast and increasing population of patients with cutaneoussquamous cell carcinoma precursors, male patients with immunosuppressive medication who develop basal cell carcinoma should be regarded as at heightened risk of cutaneous squamous cell carcinoma development and warrant closer surveillance.  \nKey words: actinic keratosis; cancer; cutaneous squamous cell carcinoma; cutaneous squamous cell carcinoma in situ ; keratinocyte carcinoma  \nSubmitted Jun 19, 2024. Accepted Nov 3, 2024  \nPublished Nov 27, 2024. DOI: 10.2340/actadv.v104.40990 Acta Derm Venereol 2024; 104: adv40990 .  \nCorr: Dr Pilvi Riihilä, MD, PhD, Department of Dermatology, University of Turku and Turku University Hospital, Hämeentie 11 TE6, FIN-20520 Turku, [Finland. E-mail: pilvi.riihila@utu.fi](Finland. E-mail: pilvi.riihila@utu.fi)  \nCutaneous squamous cell carcinoma (cSCC) is the  \nsecond most common cancer of the skin (1, 2) . The  \nSIGNIFICANCE  \nIn this study risk factors for the development of cutaneoussquamous cell carcinoma in patients with previously diagnosed precancerous skin lesions, actinic keratosis, or cutaneous squamous cell carcinoma in situ were investigated. Advanced age, male sex, comorbidity with basal cell carcinoma, and immunosuppressive medication were identified as risk factors for the development of cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma in situ or actinic keratosis as their initial lesion. Patients with actinic keratosis with high-grade dysplasia or cutaneous squamous cell carcinoma in situ as their initial lesion develop cutaneous squamous cell carcinoma faster than patients with actinic keratosis with mild or moderate dysplasia. The results of this study provide evidence for these acknowledged risk factors and emphasize that within the vast population of patients with premalignant lesions these features prompt closer surveillance. The elevated risk of cutaneous squamous cell c","cbCaij2a9F2txumZ","https://ap.wps.com/l/cbCaij2a9F2txumZ","pdf",851887,12,"English","# Study overview\n## Risk factors for progression\n## Differences by initial lesion type\n## Incidence context and background","[{\"question\":\"What was the study design and observation period?\",\"answer\":\"The study used a single-centre retrospective double-cohort design, comparing patients with actinic keratosis or cutaneous squamous cell carcinoma in situ as their initial lesion over a 5-year observation period.\"},{\"question\":\"Which factors increased the risk of developing cutaneous squamous cell carcinoma overall?\",\"answer\":\"Advanced age, male sex, comorbidity with basal cell carcinoma, and immunosuppressive medication were associated with elevated risk.\"},{\"question\":\"How did severe dysplasia affect cancer development speed?\",\"answer\":\"Patients whose initial lesion had severely dysplastic actinic keratosis or severely dysplastic cutaneous squamous cell carcinoma in situ developed cutaneous squamous cell carcinoma more rapidly than those with mild or moderate dysplasia.\"}]","Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ - A Retrospective Double-cohort Study | PDF",1790023979,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8de006cacfc6ecb0ee400e9fdeaacef.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7e1154a72ecda888c19db84817d8d83.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15f071810da183c98f3b002b2a25d069.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a1215d05b46904a22974b09ec0e9d8e.webp",980,1306]